Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15864628 | 0.88 | ALDH1A1 (0.36) | ALDH1A1TSHRTP53CYP3A4HPGD | |
| SCHEMBL1836360 | 0.85 | ALDH1A1 (0.38) | ALDH1A1TSHRHPGDSMN1; SMN2 | |
| SCHEMBL1144470 | 0.83 | ALDH1A1 (0.41) | ALDH1A1TSHRTP53CYP3A4HPGD | |
| SCHEMBL7867280 | 0.80 | TSHR (0.39) | ALDH1A1TSHRTP53CYP3A4HPGD | |
| SCHEMBL8760952 | 0.79 | ALDH1A1 (0.38) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL4924463 | 0.79 | ALDH1A1 (0.57) | ALDH1A1TSHRTP53CYP3A4SMN1; SMN2 | |
| SCHEMBL4075773 | 0.78 | ALDH1A1 (0.37) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL3220677 | 0.78 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL28675396 | 0.78 | ALDH1A1 (0.41) | ALDH1A1TSHRTP53CYP3A4HPGD | |
| SCHEMBL6053926 | 0.77 | LMNA (0.36) | ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2382315-B1 | NUCLEIC ACID PURIFICATION METHOD | QIAGEN GMBH (DE) | 2015-09-23 | — | — | EP | claimed |
| US-9102935-B2 | Nucleic acid purification method | QIAGEN GMBH (DE) | 2015-08-11 | — | — | US | claimed |
| US-20110319506-A1 | NUCLEIC ACID PURIFICATION METHOD | QIAGEN GMBH | 2011-12-29 | — | — | US | claimed |
| US-20080107909-A1 | USE OF ANTIADHESIVE PACKAGING MATERIALS FOR PACKAGING CHEMICALS AND FOODSTUFFS | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | US | claimed |
| US-7122599-B2 | Coating compositions and polymeric moulding compounds having anti-adhesion and dirt repellency properties | BYK-CHEMIE GMBH (DE) | 2006-10-17 | — | — | US | claimed |
| EP-1474491-B1 | USE OF ANTI-ADHESIVE PACKAGING MATERIALS FOR PACKAGING CHEMICALS AND FOOD | BASF AG (DE) | 2006-03-08 | — | — | EP | claimed |
| US-20050079301-A1 | Use of antiadhesive packaging materials for packaging chemicals and foodstuffs | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-14 | — | — | US | claimed |
| EP-1193303-B1 | Coating composition and polymeric molding materials having anti-adhesive, soil-release properties | BYK CHEMIE GMBH (DE) | 2005-03-09 | — | — | EP | claimed |
| US-20020103288-A1 | Coating compostions and polymeric moulding compounds having anti-adhesion and dirt repellency properties | BYK-CHEMIE GMBH (DE) | 2002-08-01 | — | — | US | claimed |
| US-12241010-B2 | Perovskite color converter and method of manufacturing the same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-03-04 | — | — | US | disclosed |
| US-12091597-B2 | Method for preparing quantum dot film, quantum dot film prepared thereby, and wavelength conversion sheet and display comprising same | INNO QD CO., LTD (KR) | 2024-09-17 | — | — | US | disclosed |
| WO-2024090759-A1 | QUANTUM DOT INK COMPOSITION, DEVICE USING SAME, AND DISPLAY DEVICE COMPRISING SAME | (주)이노큐디 | 2024-05-02 | — | — | WO | disclosed |
| CN-111601841-B | Method for manufacturing quantum dot film, quantum dot film manufactured thereby, wavelength conversion sheet including the same, and display | 株式会社尹诺丘迪 | 2023-07-07 | — | — | CN | disclosed |
| CN-112424268-B | Method for preparing quantum dot film, quantum dot film prepared thereby, wavelength conversion sheet comprising quantum dot film, and display | 株式会社尹诺丘迪 | 2023-06-23 | — | — | CN | disclosed |
| US-9115242-B2 | Copolymers which can be obtained from urethane-based, polysiloxane-containing macromonomers, processes for the preparation thereof and their use | BYK-CHEMIE GMBH (DE) | 2015-08-25 | — | — | US | disclosed |
| US-20130310464-A1 | COPOLYMERS WHICH CAN BE OBTAINED FROM URETHANE-BASED, POLYSILOXANE-CONTAINING MACROMONOMERS, PROCESSES FOR THE PREPARATION THEREOF AND THEIR USE | BYK-Dhemie GmbH (DE) | 2013-11-21 | — | — | US | disclosed |
| US-20080107909-A1 | USE OF ANTIADHESIVE PACKAGING MATERIALS FOR PACKAGING CHEMICALS AND FOODSTUFFS | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-08 | — | — | US | disclosed |
| US-7122599-B2 | Coating compositions and polymeric moulding compounds having anti-adhesion and dirt repellency properties | BYK-CHEMIE GMBH (DE) | 2006-10-17 | — | — | US | disclosed |
| US-20050079301-A1 | Use of antiadhesive packaging materials for packaging chemicals and foodstuffs | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-14 | — | — | US | disclosed |
| US-20020103288-A1 | Coating compostions and polymeric moulding compounds having anti-adhesion and dirt repellency properties | BYK-CHEMIE GMBH (DE) | 2002-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319506-A1 | NUCLEIC ACID PURIFICATION METHOD | POLL, SAMHD1, POLB | ALDH1A1 3170/4885TSHR 2755/4885TP53 2177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.